… This systematic review and meta-analysis aimed to assess … This systematic review represents
the most comprehensive … safety of molnupiravir in treating patients with mild to moderate …

… However, fewer people in the molnupiravir arm discontinued treatment as compared to the
placebo arm (1.3% vs. 3.4%, respectively) [19,20]. Other phase 3 double-blind, randomized …

… The included studies in this systematic review were (N = 60) included 39 published papers
and 21 clinical trials. After Manual addition (N = 4), the qualitative assessment included (N = …

… Authorization in three countries for the treatment of mild COVID-19. The aim of this systematic
review was to find out the safety and efficacy of Molnupiravir in SARS-COV-2 infections. …

… was reported according to the guidelines of Preferred Reporting Items for Systematic Reviews
and Meta-Analyses. Two authors independently performed a comprehensive search for …

… , there are some differences in the research results of molnupiravir. The purpose of this
study was to evaluate the efficacy and safety of molnupiravir in the treatment of COVID-19. …

… analysis and demonstrated that molnupiravir was associated with a similar hospitalization
rate as placebo in non-hospitalized COVID-19 … register of systematic reviews (registration CRD…

… or molnupiravir compared to no antiviral drug treatment for COVID-19 in non-hospitalized
adults … We searched MEDLINE, EMBASE, Scopus, Web of Science, WHO COVID-19 Research …

… We conducted a systematic review until 1 November 2022 searching for randomized
controlled trials (RCTs) involving COVID-19 patients comparing molnupiravir [±standard of care (…

… This systematic review represents the most … of molnupiravir in treating mild to moderate
COVID-19 patients. The strengths of this review include a comprehensive search; duplicate study …